RE:RE:RE:Pending NR - possibly?I agree with you that "
a company like this should be soaring"; however, this particular company has had issues that provide headwinds. Some would say that internal sabotage by former employess and external sabotage by the State of Texas were the root cause of the issue. Others would say that the company has not proven they can successfully onboard large numbers. Probably both are true.
Certainly, the company has signed up enough clients/patients already to drive the value eventually to multi-dollar status. And under current circumstance (COVID-19), that expectation of future success combined with future contracting expectations might drive the price even further north, but the issue of execution remains.
So, once that gets proven out, anything is possible, whether or not there is a pandemic. We might see lots of anecdotal evidence over the next several months (NRs, webinars, etc.) about execution, but the actual confirming financials will probably take longer.
I guess we all either move on to something more exciting or stick around for the long term potential payoff. I'm in the latter group.
Ziondog wrote: In a normal time, yes. But during a pandemic when online healthcare has taken such an important position in the spotlight, a company like this should be soaring. The silence as the stock remains flat and even retrenches a bit is disappoining for stockholders.